CG Oncology, Inc. Common stock (CGON) NASDAQ

40.94

-0.67(-1.61%)

Updated at December 12 03:59PM

Currency In USD

Valuation

Market Cap1.79B
Enterprise Value1.54B
P/E Ratio-29.17
PEG Ratio1.92
Price/Sales Ratio1,411.72
Price/Book Ratio4.57
Enterprise/Revenue1,394.29
Enterprise/EBITDA-16.83

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-49.53
Operating Margin-82.85

Management Effectiveness

Return On Assets-0.15
Return On Equity-0.15

Income Statement

Revenue1.14M
Revenue/Share0.03
Gross Profit1.14M
EBITDA-114.63M
Net Income-88.04M
Diluted EPS-1.41

Balance Sheet

Total Cash680.26M
Total Cash/Share8.87
Total Debt7.24M
Total Debt/Equity0.01
Current Ratio22.79
Book Value Per Share8.96

Price History

52-Week Change42.35
52-Week High46.01
52-Week Low14.8
Moving Average 50 Days41.89
Moving Average 200 Days30.5

Statistics

Average Volume939,376
Shares Outstanding74.97M
% Held by Institutions101.87

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A